Turn Therapeutics (TTRX) posts updated investor presentation dated Nov 10, 2026; exhibit text lacks financial detail

Turn Therapeutics Inc.

Updated investor presentation dated November 10, 2026 released; no separate press release, earnings release or financial-data tables accompany it.
The appended exhibit text contains only the cover slide and a forward-looking-statements safe-harbor page; no revenue, cash, pipeline or trial data is legible.
Signed by Chief Executive Officer Bradley Burnam on November 10, 2026; company is an emerging growth company.
No operational, clinical, financial or guidance changes are disclosed in the readable text; investors must obtain the full deck from the company.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.